Treace Medical Concepts (TMCI) Preferred Shares (2020 - 2021)

Treace Medical Concepts (TMCI) posted Preferred Shares of $7.9 million for Q1 2021, little changed on a QoQ basis from $7.9 million in Q4 2020.

Treace Medical Concepts (TMCI) Preferred Shares (2020 - 2021) Analysis & Trends

Treace Medical Concepts' Preferred Shares history runs 2 years deep, the most recent figure standing at $7.9 million for Q1 2021.

  • Quarterly Preferred Shares changed N/A year-over-year to $7.9 million in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $7.9 million (changed N/A YoY) and the FY2020 annual result came in at $7.9 million, changed N/A from the prior year.
  • Preferred Shares was $7.9 million for Q1 2021 at Treace Medical Concepts, roughly flat from $7.9 million in the prior quarter.
  • Across five years, Preferred Shares topped out at $7.9 million in Q4 2020 and bottomed at $7.9 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Treace Medical Concepts 261.60 Mn 209.75 Mn 37.41 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 7.94 Mn
Dec 31, 2020 7.94 Mn